|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | International Conference on Harmonization: Draft Guidance on E2B(R) Clinical Safety Data Management: Data Elements for Transmission of Individual Case Safety Reports; Availability显示文摘 | FDA | 2005 | Fed Regist2005，70，57： | 1 |
| 2 | Food labeling: trans fatty acids in nutrition labeling, nutrient content claims, and health claims 显示文摘 | Food and Drug Administration HHS | 2003 | Fed Regist2003，68，41： | 1 |
| 3 | E2D: Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting显示文摘 | ICH | 2003 | Fed Regist2003，68，53： | 1 |
| 4 | National emission standards for hazardous air pollutants from the synthetic organic chemical manufacturing industrial and seven other processes 显示文摘 | Environmental protection Agency(EPA) | 1992 | Fed Regist1992，57，62： | 1 |
| 5 | Final standard显示文摘 | Occupational exposure to ethylene oxide--OSHA | 1984 | Fed Register1984，49，25： | 1 |
| 6 | Drug administration, revisions to labeling re- quirements for blood and blood components, including source plasma显示文摘 | FOOD H H S | 2012 | Final Rule Fed Regist2012，77，1： | 1 |
| 7 | Weight control drug products for over the counter human use, certain active ingredients显示文摘 | USA Food and Drug Administration | 1991 | Fed Regist1991，56，37： | 1 |
| 8 | medicare,medicaid,and CLIA programs:regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA)显示文摘 | United States Department of Health and Human Services | 1992 | Fed Regist1992，57，40： | 1 |
| 9 | Revisions to exceptions applicable to certain human cells,tissues,and cellular and tissue-based products显示文摘 | F DA H HS | 2016 | Fed Regist2016，81，40： | 1 |
| 10 | Bar code label requirement for human drug products and biological products 显示文摘 | Food and Drug Administration HHS | 2004 | Fed Regist2004，2669，38： | 1 |
| 11 | Guidelines for registering pesticides in the United States显示文摘 | US EPA | 1975 | Fed Regist1975，40，26： | 1 |
| 12 | Environmental protection agency rule sand regulations显示文摘 | U S | 1991 | Fed Regist1991，56，： | 1 |
| 13 | Clinical laborato- ry improvement amendments of 1988 :final rule显示文摘 | Department of Health and Human Services Centers for Medicare & Medicaid Services | 2003 | Fed Register2003，24，16： | 1 |
| 14 | Final rule with comment period显示文摘 | Medicare medicaid and CLIA program regulations implementing the clinical laboratory improvement amendment of 1988(CLIA) | 1992 | Fed Regist1992，57，40： | 1 |
| 15 | International conference on harmonization;guidance on impurities:residual solvents显示文摘 | Hubbard WK | 1997 | Fed Regist1997，62，67： | 1 |
| 16 | Medicare and Medicaid programs; electronic health recordincentive program, final rule显示文摘 | Centers for Medicare Medicaid Services (CMS) HHS | 2010 | Fed Regist2010，75，144： | 1 |
| 17 | GRAS status of sulfating for use on fresh and frozen foods revoked显示文摘 | ANON | 1986 | Fed Regist1986，51，25： | 1 |
| 18 | Schedules of controlled substances : placement of suvorexant into Schedule IV 显示文摘 | Drug Enforcement Administration Department of Justice | 2014 | Finalrule Fed Regist2014，79，51： | 1 |
| 19 | Pesticides tolerance for sulfur dioxid显示文摘 | ANON | 1989 | Fed Regist1989，54，20： | 1 |
| 20 | Final Rule显示文摘 | Medicare Medicaid and CLIA program: Regulations im- plementing the clinical laboratory improvement amend- ments of 1988(CLIA) | 1992 | Fed Regist1992，57，40： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员